Let's Get Started

Biotech

BTTX Stock Price is up 23%, can it go higher? URGENT

Jun 24, 2022

Better Therapeutics BTTX stock price is up 23% in the last 5 days & volume is down 89% (WOW), but is it over for this breakout stock?

How is it that volume is down so much but it is up 23%?

There is an old adage, “two heads are better than one”, so let’s collaborate on BTTX and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for BTTX, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for BTTX is, a 🔥🔥2 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Better Therapeutics Company Information

Company Name: Better Therapeutics Inc.

Ticker: BTTX

Exchange: NASDAQ

Website: https://www.bettertx.com/

Better Therapeutics Company Summary:

Better Therapeutics, Inc. develops software-based prescription digital therapeutics for treating diabetes, heart disease, and other cardiometabolic conditions. It engages in developing a proprietary platform for the development of FDA-regulated, software-based solutions for type 2 diabetes, heart disease and other conditions. The company was founded by Kevin J. Appelbaum and David P. Perry in April 2015 and is headquartered in San Francisco, CA.

BTTX stock price is due to News?

June 8th

Announced that the U.S. Patent and Trade Office (USPTO) has granted their first patent, granting twenty years of exclusivity for a number of key features core to the company’s digital therapeutics platform, designed to help treat cardiometabolic diseases through the delivery of digital behavioral therapy as a PDT.

BTTX

BTTX Stock Price HOT Stock Grade:

The official heat level for BTTX is, a 🔥🔥2 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

BTTX Trading Volume

The volume, is trading at an increase of 23% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

BTTX Technicals

The technical analysis “chart reading”, it is bullish and I like it. The one day, 5 day and ten day chart looks great. Keep this on your watchlist.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

BTTX News Cycle

The news, there is no significant news.

BTTX Fundamentals

The fundamentals, there is no exciting financial filings associated with this stock,.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

BTTX Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 2 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

ACADIA Pharmaceuticals ACAD Stock Price is ready to bounce? Exclusive Report

Jun 21, 2022

ACADIA Pharmaceuticals ACAD Stock Price has been trying to recover since it’s July high of almost $25.33.

Wondering why this stock is having such a hard time and if it can break the overall trend? Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! ACAD Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

ACADIA Pharmaceuticals Company Information

Company Name: ACADIA Pharmaceuticals Inc.

Ticker: ACAD

Exchange: NASDAQ

Website: https://acadia.com/

ACADIA Pharmaceuticals Company Summary:

ACADIA Pharmaceuticals, Inc. operates as a biopharmaceutical company. It focuses on the development and commercialization of medicines to address unmet medical needs in central nervous system, or CNS, disorders. The firm’s products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.

ACAD stock price is due to News?

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the outcome of the U.S. Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee (PDAC) meeting for pimavanserin for the treatment of hallucinations and delusions associated with Alzheimer’s disease psychosis (ADP). The PDAC voted 9 to 3 that the evidence presented does not support a conclusion that pimavanserin is effective for the treatment of hallucinations and delusions in the ADP population.

ACAD 5 Day Chart

ACAD Stock Price Technical Analysis:

It is in consolidation mode right now and it is a wait and see game!

I really like if it can beat $14 because, like often, the sell off was emotional and there will be a bounce.

Wait for the indicators to pop off though.


[thrive_leads id=’14274′]

read more

TRHC Stock Price is consolidated and ready for a run? Urgent Report

Jun 21, 2022

Tabula Rasa HealthCare TRHC Stock Price has been trying to recover since it’s July high of almost $52.50. It is trading at 1,600% over normal volume!

Wondering why this stock is having such a hard time and if it can break the overall trend? Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! TRHC Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Tabula Rasa HealthCare Company Information

Company Name: Tabula Rasa HealthCare Inc.

Ticker: TRHC

Exchange: NASDAQ

Website: https://www.tabularasahealthcare.com/

Tabula Rasa HealthCare Company Summary:

Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services. Its brands include CareKinesis, Capstone Risk Adjustment Services, PACElogic, TruChart, PeakTPA, PersonifilRx, and Pharmastar. The MedWise HealthCare segment provides Medication Therapy Management, or MTM, software and services for Medicare, Medicaid, and commercial health plans, and also provides a cloud-based patient engagement software and services. It offers cloud-based software and clinical pharmacist services through its brands, including MedWise, SinfoníaRx, RxCompanion, PrescribeWellness, and DoseMeRx. The company was founded by Calvin H. Knowlton, Orsula V. Knowlton, and Michael Greenhalgh in April 2009 and is headquartered in Moorestown, NJ.

TRHC stock price is due to News?

June 21, 2022 /PRNewswire/ — Tabula Rasa HealthCare, Inc.(R) (TRHC)(NASDAQ: TRHC), a leading healthcare technology company advancing the safe use of medications, announced today that it has entered into a definitive agreement to sell its PrescribeWellness business, a provider of best-in-class patient relationship management solutions, to Transaction Data Systems (TDS).

TRHC 5 Day Chart

TRHC

TRHC Stock Price Technical Analysis:

Based on the announcement today that it they entered into a definitive agreement to sell its Prescribe Wellness business this could make it bounce. However, there should be a pullback and I would wait until that time.


[thrive_leads id=’14274′]

read more

Nascent Biotech NBIO Stock Price is ready for another run? URGENT Update

Jun 14, 2022

Nascent Biotech NBIO Stock Price his at a 52 week high, could it go even higher?

Wondering why this stock is breaking records and the rest of the market is struggling?

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! NBIO Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Nascent Biotech Company Information

Company Name: Nascent Biotech Inc.

Ticker: NBIO

Exchange: OTC

Website: https://www.nascentbiotech.com/

Nascent Biotech Inc. Company Summary:

Nascent Biotech, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of monoclonal antibodies for the treatment of various forms of cancer. It focuses on biologic drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Its products include Pritumumab, CLNH5, and MultiPharm. The company was founded in July 15, 2014 and is headquartered in Vero Beach, FL.

NBIO stock price is due to News?

June 7, 2022 / Nascent Biotech, Inc. (OTCQB:NBIO) (“Nascent Biotech”, “Nascent”, or the “Company”), a clinical-stage biotechnology Company pioneering the development of monoclonal antibodies targeting treatment of various cancers and viral infections, is pleased to announce the completion of the Third cohort in dosing patients for its Phase I trial for Brain Cancer. After reviewing the data gathered from the first three cohorts, this milestone will allow the trial to advance to the fourth and possibly final cohort.

NBIO 5 Day Chart

NBIO

NBIO Stock Price Technical Analysis: NBIO Stock Price

The PPS is up over 73% over the last month. The volume is also up, to be exact it is up 254%!

I like the stock a lot, pay attention its about to pop in my opinion!


[thrive_leads id=’14274′]

read more

Soleno Therapeutics SLNO is looking horrible! Can it go higher? URGENT

Jun 14, 2022

SLNO Stock Price has been trying to recover since it’s July high of almost $1.18.

Wondering why this stock is having such a hard time and if it can break the overall trend?

Before we do, remember to stop what you are doing and 👇 Sign up for our newsletter to get the latest breakout stocks and trending stocks!


[thrive_leads id=’14274′]

Before we get started, I wanted to introduce myself to you. Hi 🙋‍♂️ I’m Alexander Goldman and I have been successfully trading breakout stocks and trending stocks for two decades now.

I’m now helping traders find breakout stocks. My claim to fame is the expert at finding trending stocks.

What do I mean by big winners?

Stocks that move more than 100% in a month! SLNO Stock Price could?

Does that always happen, NO! But, I’m very good! Take a look at this article I wrote, where I called 5 stocks, 3 losers and 2 winners and they all did what I thought!

The article is HERE where I shine a spotlight on trending stocks and breakout stocks!

Now, let’s go over some of the basic information on this stock before we get in the technical analysis

Soleno Therapeutics Inc. Company Information

Company Name: Soleno Therapeutics Inc.

Ticker: SLNO

Exchange: NASDAQ

Website: https://soleno.life/

Soleno Therapeutics Inc. Company Summary:

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

SLNO stock price is due to News?

May 19, 2022

Announced presentations at the upcoming 2022 European Congress of Endocrinology (ECE), which is being held May 21-24, 2022, in Milan, Italy.

SLNO 5 Day Chart

SLNO stock price

SLNO Stock Price Technical Analysis:

There is great opportunities to scalp some serious returns with this fast mover but right now is not the time. There is too much downward pressure but I would like it if it was around $.17 and confirmed a breakout, so keep your eyes on this beast because it is good for 20-40% gains when timed correctly.


[thrive_leads id=’14274′]

read more

PPCB Stock Price is down BIG, is it ready to BOUNCE? URGENT Report!

Jun 13, 2022

Propanc Biopharma PPCB stock price is up -42% in the last 5 days & volume is up 170%, but is it ready to bounce?

There is an old adage, “two heads are better than one”, so let’s collaborate on PPCB and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for PPCB, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for PPCB is, a 🔥1 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Propanc Biopharma Company Information

Company Name: Propanc Biopharma Inc.

Ticker: PPCB

Exchange: OTC

Website: https://www.propanc.com/

Propanc Biopharma Company Summary:

Propanc Biopharma, Inc. is a development-stage healthcare company, which engages in the research and development of cancer treatments. The company focuses on the treatment of pancreatic, ovarian, and colorectal cancer. It offers its product pipeline, including PRP and POP1. The company was founded by James Nathanielsz and Julian Kenyon on October 15, 2007 and is headquartered in Camberwell, Australia.

PPCB stock price is due to News?

June 1st

Announced that Chief Scientific Officer and Co-Founder, Dr Julian Kenyon MD, MB, ChB, believes the reduced toxicity of PRP compared to standard treatment approaches will impact cancer patient lives significantly. Many standard therapies for advanced cancer urgently need improvement, generally providing modest benefits and frequently causing adverse effects. Propanc’s focus is to provide oncologists and their patients with therapies for metastatic cancer which are more effective than current therapies and have a substantially reduced side effect profile. According to Cancer Treatment Centers of America, for all the advances made in cancer treatment over the past several decades, one statistic has remained unchanged: Metastatic cancer accounts for up to 90% of all cancer deaths in the United States each year.

PPCB Stock Price HOT Stock Grade:

The official heat level for PPCB is, a 🔥 1 out of 4 . Here are my takeaways on it and why it is just a 1 out of 4. Do you agree?

PPCB Trading Volume

The volume, is trading at an increase of 170% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

PPCB Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

PPCB News Cycle

The news, there is no significant news.

PPCB Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “170% growth”!

PPCB

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

PPCB Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 1 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

AERC Stock Price is so consistent, can it go higher? URGENT

Jun 7, 2022

AeroClean Technologies AERC stock price is up 447% in the last 5 days & volume is up 9,400%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on AERC and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for AERC, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for AERC is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

AeroClean Technologies Company Information

Company Name: AeroClean Technologies

Ticker: AERC

Exchange: NASDAQ

Website: https://aeroclean.com/

AeroClean Technologies Company Summary:

AeroClean Technologies, Inc. is an interior space air purification technology company. Its products include Purgo and PurgoLift. The company was founded by Amin J. Khoury, David Helfet, and Mark Krosney on September 2, 2011 and is headquartered in Palm Beach, FL.

AERC stock price is due to News?

June 06, 2022 (GLOBE NEWSWIRE) — AeroClean Technologies (“AeroClean” or the “Company”) (Nasdaq: AER

Announced that the U.S. Food and Drug Administration (FDA) has granted AeroClean’s Pūrgo technology 510(k) clearance, classifying it as a Class II Medical Device. The clearance was provided after a thorough review of the patented Pūrgo device, which utilizes patented germicidal UV-C LED air purification technology and is proven to eliminate 99.99% of harmful airborne microorganisms, including bacteria, fungi and viruses, like COVID-19. As experts in Indoor Air Quality (IAQ), AeroClean provides healthcare facilities, businesses, hospitality venues and government agencies with the highest medical grade air purification and air sanitization technology.

AERC

AERC Stock Price HOT Stock Grade:

The official heat level for AERC is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

AERC Trading Volume

The volume, is trading at an increase of 8,491% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

AERC Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

AERC News Cycle

The news, there is significant news. Look at this, Announced that the U.S. Food and Drug Administration (FDA) has granted AeroClean’s Pūrgo technology 510(k) clearance, classifying it as a Class II Medical Device.

AERC Fundamentals

The fundamentals, there is exciting financial filings associated with this stock, “they are producing revenue”

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

AERC Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

IMMX Stock Price is so consistent, can it go higher? URGENT

Jun 2, 2022

Immix Biopharma IMMX stock price is down -18% in the last 5 days & volume is up 1559%, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on IMMX and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for IMMX, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for IMMX is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

Immix Biopharma Company Information

Company Name: Immix Biopharma Inc.

Ticker: IMMX

Exchange: NASDAQ

Website: https://www.immixbio.com/

Immix Biopharma Company Summary:

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

IMMX stock price is due to News?

May 20, 2022

Announced positive interim study data showing that after one cycle of treatment, ImmixBio’s lead candidate IMX-110 produced 75% survival vs. 0% survival for Trabectedin (sold as YONDELIS (R) by Janssen, a Johnson & Johnson Company, a U.S. FDA approved drug) in a connective tissue cancer Soft Tissue Sarcoma (STS) mice study.

IMMX

EIMMX Stock Price HOT Stock Grade:

The official heat level for IMMX is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

IMMX Trading Volume

The volume, is trading at an increase of 82% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

IMMX Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

IMMX News Cycle

The news, there is no significant news.

IMMX Fundamentals

The fundamentals, there is no exciting financial filings associated with this stock. It’s a start up.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

IMMX Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more

MLTX Stock Price is so consistent, can it go higher? URGENT

Jun 2, 2022

MoonLake Immunotherapeutics MLTX stock price is up 45% in the last 5 days & volume isaverage, but is it over for this breakout stock?

There is an old adage, “two heads are better than one”, so let’s collaborate on MLTX and compare notes.

In this in depth report, I look at 5 KPIs: Technical Analysis, Volume, News Cycle, Fundamentals & awareness campaigns. I believe the stock market is not gambling, it is also not fool proof, but I have developed a dependable system. I have found some critical components to success for MLTX, tell me what you think.

Before we get started, I like being methodical and easy to understand so I have developed a ranking system for my stocks. I call it, Alexander Goldman’s “HOT Stock Ranking!”

CA:XBC stock price

The official heat level for MLTX is, a 🔥🔥🔥 3 out of 4

Before I get ahead of myself and just jump right into this exciting breakout stock, I wanted to introduce myself.

Hello 🙋‍♂️ My name is Alexander Goldman. I have been trading small cap stocks, breakout stocks and trending stocks for 20 years now. I’m accredited for establishing the coveted HOT Stock Reporting system for breakout stocks.

To find out more about my story, CLICK HERE


[thrive_leads id=’28419′]

MoonLake Immunotherapeutics Company Information

Company Name: MoonLake Immunotherapeutics Inc.

Ticker: MLTX

Exchange: NASDAQ

Website: https://moonlaketx.com/

MoonLake Immunotherapeutics Company Summary:

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MLTX stock price is due to News?

May 12, 2022

MoonLake Immunotherapeutics starts Phase 2 trial of the Nanobody(R)Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa

  • First Phase 2 trial in hidradenitis suppurativa using the higher clinical response level of HiSCR75 as the primary endpoint
  • Trial evaluates sonelokimab, an investigational Nanobody(R) with an innovative mode of action designed to treat and elevate patient outcomes for inflammatory disease

MLTX

MLTX Stock Price HOT Stock Grade:

The official heat level for MLTX is, a 🔥🔥🔥 3 out of 4 . Here are my takeaways on it and why it is just a 3 out of 4. Do you agree?

MLTX Trading Volume

The volume, is trading at an increase of 82% over the average which indicates a higher demand in the stock.

Trading 101: volume is measured in the number of shares traded. Traders look to volume to determine liquidity and combine changes in volume with technical indicators to make trading decisions. So, let’s take a look at the technical indicators.

MLTX Technicals

The technical analysis “chart reading”, it is bullish and has been that way since the early part of this month with a steady ascending channel.

Trading 101: Technical indicators are technical tools that help in analyzing the movement in the stock prices whether the ongoing trend is going to continue or reverse. It helps the traders to make entry and exit decisions of a particular stock. Technical indicators can be leading or lagging indicators.

MLTX News Cycle

The news, there is significant news:

‘First Phase 2 trial in hidradenitis suppurativa using the higher clinical response level of HiSCR75 as the primary endpoint
Trial evaluates sonelokimab, an investigational Nanobody(R) with an innovative mode of action designed to treat and elevate patient outcomes for inflammatory disease”MLTX Fundamentals

The fundamentals, there is no exciting financial filings associated with this stock to share.

Trading 101: Fundamental trading is a method where a trader focuses on company-specific events to determine which stock to buy and when to buy it. Trading on fundamentals is more closely associated with a buy-and-hold strategy rather than short-term trading.

MLTX Awareness

Marketing efforts “Awareness Campaigns”, I have not found marketing efforts around the investor awareness of this company. Hence the 3 out of 4. Do you agree? Write me a line at [email protected]

Again, two heads are better than one, let’s work together to have the best trading year of our lives!

To receive my 🔥🔥🔥🔥 HOT stock as a thank you for joining our FREE newsletter, sign up today.

To find out more about my story, CLICK HERE

👇 Sign up for our newsletter to get the latest 🔥🔥🔥🔥 HOT stocks and we can compare notes!👇


[thrive_leads id=’28419′]

read more